Delivery Order 75N95021D00026-75N98026F00002
Award Date 9/12/26
Potential Completion Date 9/11/28
Potential Value $222K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
- The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $1,523 firm fixed price delivery order contract to IIT Research Institute of Chicago, Illinois. This order is against IIT Research Institute's indefinite-delivery/indefinite-quantity prime contract vehicle for the Pharmacology and Toxicology for Therapeutics Program, which provides research support services. The scope of work under this order involves a kickoff meeting to support the program's...
- This federal contract award is for $201,969.00 and was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology. The contract is for non-GLP dose range finding (DRF) studies to be completed by December 2023. This appears to be a task order issued under IITRI's $174.5 million single-award Pharmacology and Toxicology for Therapeutics Program contract...
- The National Institute on Drug Abuse awarded a firm fixed-price delivery order valued at $258,274 to IIT Research Institute (IITRI) on March 1, 2024, for Management and Operations Support under Performance Area 1. The contract is scheduled for completion by February 28, 2027, and will be performed in Chicago, Illinois. This delivery order represents work conducted under one of IITRI's larger indefinite delivery/indefinite quantity contract vehicles with the National Institutes of Health. No...
- This is a federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The $224,716.00 contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle called the Pharmacology and Toxicology for Therapeutics Program, which has a total ceiling value...
- IIT Research Institute was awarded a $1.57 million cost-plus-fixed-fee delivery order against the CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract by the National Institutes of Health's National Center for Advancing Translational Sciences. The task order is for non-clinical safety assessment of SPIF to support the chronic graft-versus-host disease indication. Work will be performed in Chicago, Illinois through November 2020. IIT Research Institute will conduct...
- This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...
- The National Cancer Institute awarded a definitive contract to IIT Research Institute for preclinical toxicology studies of drugs developed for cancer and other diseases on July 1, 2011, with a ceiling value of $11,526,862.22 under cost-plus-fixed-fee pricing. Place of performance is Chicago, IL. The contract runs through June 30, 2017. IIT Research Institute is a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, specializing in preclinical drug...
- The National Cancer Institute awarded a definitive cost-plus-fixed-fee contract to IIT Research Institute (IITRI), a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, for preclinical toxicology and pharmacology services supporting drug development for cancer, AIDS, and AIDS-related illnesses. The contract, awarded on April 1, 2004, carries a ceiling value of $159.3 million with an ultimate completion date of June 30, 2016, and will be performed...
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $271,488 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, a division of the Illinois Institute of Technology, will provide in vitro and in vivo toxicology studies support services to NCATS under cost-plus-fixed-fee pricing from June 2018 through August 2019. The prime contractor will...